No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

byKathleen Lau

May 1, 2021

in StudyGraphics

Association of oral corticosteroid bursts with severe adverse events in children

RelatedReports

Majority of pediatric medication-related visits to emergency department are preventable

Oncology

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

January 28, 2026

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine

Non-drug interventions highly efficacious at reducing depressive symptoms in people with dementia

2 Minute Medicine Rewind May 3, 2021

Delays in surgical intervention do not increase odds of appendiceal perforation

Bariatric surgery vs community weight management for idiopathic intracranial hypertension

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports